That big R&D PARP win Clovis CEO Mahaffy touted a few weeks ago? The FDA isn’t buying it – Endpoints News

Two years ago, French researcher and microbiologist Didier Raoult published a paper that, at the time, was cited as an inspiration for former President Donald Trump’s obsession with hydroxychloroquine as a treatment for Covid-19. And now, the researcher is under the French government’s bullseye for ethical breaches in research.

Here’s what we know: the French Medicines Agency, or ANSM, said that it will refer criminal charges to the public prosecutor in Marseilles against Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, or URMITE, a local hospital-university institute (IHU) for infectious diseases that has been run by Raoult for over a decade.

Endpoints News

Keep reading Endpoints with a free subscription

Unlock this story instantly and join 141,400+ biopharma pros reading Endpoints daily — and it’s free.

Give a Comment